Three-Drug Combination Slows Progression of Advanced Kidney Cancer
Immunotherapy – Targeted Drug Combination Improves Survival in Advanced Kidney Cancer
Seeking Signs of Synergy: The Origins of PARP and PI3K Inhibitors
New Clinical Tool for Clonal Hematopoiesis Identifies Patients at High Risk for Blood Cancer
Benefit of Chemotherapy for Patients With Early-Stage Breast Cancer Varies by Tumor Anatomy
Patients With Detectable PSA After Radical Prostatectomy Have Good Long-Term Outcomes, UCSF Researchers Find
High Concentrations of Immune Cells Within Tumors Associated with Longer Patient Survival
Clinical Trial Shows That Adding Bevacizumab to Targeted Drug and Chemotherapy Produces Striking Activity Against HER2-Positive Metastatic Gastroesophageal Adenocarcinoma
Mount Sinai Achieves Highest Rating From Society of Thoracic Surgeons for Ground-Breaking Esophagectomy Program
UCSF Surgical Oncologists Present Clinical Findings at International Conference
Cancer Patients & COVID
Internationally renowned cancer researcher joins cancer center’s research team
David Tom Cooke recognized for care and compassion in medicine
Autologous muscle derived cells for treatment of tongue dysphagia
Blood and Marrow Transplant Program
Showing 226 - 240 of 1027 results
Previous| 1... 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 ...69 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
